MaxLinear saw a welcome improvement to its Relative Strength (RS) Rating on Monday, rising from 80 to 83.
IBD's proprietary rating measures share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the market's biggest winners tend to have an 80 or higher RS Rating in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to form a base and break out.
The company posted 0% earnings growth in its most recent report. Revenue gains came in at -26%.
The company holds the No. 30 rank among its peers in the Electronics-Semiconductor Fabless industry group. Broadcom, Rambus and NVIDIA are among the top 5 highly rated stocks within the group.
RELATED:
Chip Stocks To Watch And Semiconductor Industry News
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
